SMVZX
Price
$12.65
Change
-$0.08 (-0.63%)
Updated
Aug 15 closing price
Net Assets
1.1B
VMVIX
Price
$66.94
Change
-$0.25 (-0.37%)
Updated
Aug 15 closing price
Net Assets
31.04B
Interact to see
Advertisement

SMVZX vs VMVIX

Header iconSMVZX vs VMVIX Comparison
Open Charts SMVZX vs VMVIXBanner chart's image
Virtus Ceredex Mid-Cap Value Equity R6
Price$12.65
Change-$0.08 (-0.63%)
VolumeN/A
Net Assets1.1B
Vanguard Mid-Cap Value Index Investor
Price$66.94
Change-$0.25 (-0.37%)
VolumeN/A
Net Assets31.04B
SMVZX vs VMVIX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
SMVZX vs. VMVIX commentary
Aug 18, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is SMVZX is a Buy and VMVIX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VMVIX has more cash in the bank: 31B vs. SMVZX (1.1B). VMVIX pays higher dividends than SMVZX: VMVIX (2.10) vs SMVZX (1.13). SMVZX was incepted earlier than VMVIX: SMVZX (11 years) vs VMVIX (19 years). SMVZX (0.88) is less costly to investors than VMVIX (0.19). SMVZX is a more actively managed with annual turnover of: 141.00 vs. VMVIX (19.00). VMVIX has a lower initial minimum investment than SMVZX: VMVIX (3000) vs SMVZX (2500000). VMVIX annual gain was more profitable for investors over the last year : 7.67 vs. SMVZX (0.47). VMVIX return over 5 years is better than : 65.08 vs. SMVZX (24.20).
SMVZXVMVIXSMVZX / VMVIX
Total Expense Ratio0.790.19416%
Annual Report Gross Expense Ratio0.880.19463%
Fund Existence11 years19 years-
Gain YTD4.8055.17793%
Front LoadN/AN/A-
Min. Initial Investment2500000300083,333%
Min. Initial Investment IRAN/AN/A-
Net Assets1.1B31B4%
Annual Yield % from dividends1.132.1054%
Returns for 1 year0.477.676%
Returns for 3 years13.2017.4676%
Returns for 5 years24.2065.0837%
Returns for 10 years5.2687.806%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GTHP0.280.02
+8.35%
Guided Therapeutics, Inc.
DSEEY7.760.14
+1.90%
Daiwa Securities Group, Inc.
FBSFF18.00N/A
N/A
Fabasoft AG
CWPS26.76N/A
N/A
Conwest Associates, L.P.
KSRYY7.82-0.28
-3.52%
Kose Corp.